JVJ Vodicka

J Vodicka

*This is an algorithmically generated author record based on publicly available information.

J Vodicka has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 February 2016
      • Vol. 95  (2) , 91-4

    [Castleman disease - unusual finding after operation of retroperitoneal tumor of young patient].

    by J Fichtl, V Třeška, J Vodička, R Šulc, O Hes, R Tupý

    Castleman disease is rare diagnosis. It was first mentioned in literature in 1954 by doctor Castleman and Lown. It is rare sickness which primary affects lymfatic nodes. There are four histo-morfologic subtypes and two clinic manifestations (uni and mulicentric). Comon clinical picture is simple lymfadenopathy of neck, medistinal a retroperitonal lymfatic nodes. Signs of this disease are heterogenic and depend on histological subtype. Also prognosis depends on type of illness. It should take place as benign diagnosis (unicentric form) but also can be potencionally malignant form which shlould exacerbate to malignant lymfoproliferation (multicentric form). Authors present the case of 29 years old men with clinical manifestation (jundice, intermitent bowel obstruction) of lagre retroperitoneal tumor in subhepatal localization. The treatment was radical surgical extirpation, surgery was without complications. Definitive histological diagnosis was confirmed as hyaline-vascular type of Castleman disease. Because the patient´s clinical form was multicentric, he is now undergoing adjuvant oncological treatment. Castleman disease reproperitoneal tumor.


    • 1 April 2014
      • Vol. 93  (4) , 194-201

    [Pulmonary metastases - 12-year experience with surgical therapy].

    by J Vodička, V Spidlen, V Simánek, J Safránek, J Fichtl, P Mukenšnabl, M Roušarová

    Nowadays, radical surgical therapy of selected secondary pulmonary tumours is a generally accepted therapeutic procedure that has been proven to extend long-term survival of the patients with acceptable perioperative morbidity and mortality. The authors present a retrospective analysis of a set of patients who underwent surgery for pulmonary metastases of various tumours in a 12-year period. In 2001-2012, 159 patients with secondary pulmonary tumours were operated on at the authors department, of whom 80 were men; the median age was 65 years. Solitary metastases were present in 112 patients (70.4%); the other patients had multiple metastases; 24 patients (15.1 %) suffered from bilateral involvement, and 6 patients (3.8%) suffered from relapsed metastatic disease after previous radical surgery. Colorectal carcinoma metastases were diagnosed in most cases (75 people - 47.2%). The median disease-free period from the surgery of the primary tumour was 27 months in the patient set. In total, 166 unilateral (87.4%) and 24 bilateral surgeries were performed using one- or two-stage procedure (12.6%). Precise laser excisions represented the most common type of surgery (59 procedures - 31.1%). In total, 296 metastases were radically resected, and 13 were treated using radiofrequency ablation. Perioperative morbidity was 13.2% with a zero lethality rate. 90 operated patients (56.6%) still survive after the metastasectomy, with median survival of 44 months. The overall 3-year survival in the set was 59%, and 5-year survival was 39%. The number of metastases is a statistically significant factor affecting survival in the patient cohort with colorectal carcinoma metastases, the risk of death being 2.7 times higher in patients with 2 and more colorectal carcinoma metastases. 68 patients (42.8%) live without progression of the disease after the metastasectomy, with the median disease-free interval of 29 months. In total, 43% of the patients were free of any signs of relapse or disease progression for 3 years, and 27% for 5 years. The risk of disease progression is 2.1 times higher in patients with 2 and more metastases of any tumour, and for colorectal carcinoma this risk is 2.3 times higher. The achieved results confirm the positive role of pulmonary metastasectomy in disseminated tumour therapy. The number of metastases is the decisive prognostic factor affecting both long-term survival of operated patients and their DFI.


    • 1 September 2013
      • Vol. 92  (9) , 488-93

    [Liver and pulmonary metastases of the colorectal carcinoma - the experience of the Department of Surgery, University Hospital in Pilsen].

    by V Třeška, J Vodička, V Špidlen, T Skalický, J Fichtl, V Šimánek, J Šafránek, A Sutnar, J Brůha

    Liver and pulmonary metastases of the colorectal carcinoma develop in about 20-70%, resp. in 10-22% patients with the colorectal carcinoma. Their treatment is still a matter of discussion. The aim of our study was to evaluate the results of surgical treatment as a part of the multimodal approach. 30 patients with liver and pulmonary colorectal metastases were operated on between 2002 and 4/2013. The average age was 62.8 ± 10.7 years. 19 patients had metachronous and 11 synchronous metastases. The liver metastases preceded pulmonary in 14 cases, and vice versa in 5 patients. Both types of metastases developed in seven patients simultaneously. Liver resection was performed in 23, radiofrequency ablation (RFA) in 7 patients. Laser pulmonary metastasectomy was performed in 15, pulmonary resection in 14 and RFA in one patient. The liver procedure preceded pulmonary in 25 patients. 73.3% patients had adjuvant oncological treatment. 30 days mortality rate was 3.3% (N=1) for the actinomycotic sepsis complicated with MRSA infection. Morbidity rate was 10%. Recurrence of liver metastases developed in 6 patients. RFA was performed in all patients. The median of overall and disease free survival was 6.9, resp. 1.1 years. Surgical treatment as a part of the multimodal treatment is the only radical treatment for patients with liver and pulmonary metastases. It offers good long-term results.

    • 1 April 2013
      • Vol. 92  (4) , 195-200

    [Mediastinitis after esophageal perforation].

    by J Safránek, J Geiger, J Klecka, T Skalický, V Spidlen, V Veselý, J Vodicka

    Assessment of therapy in patients with mediastinal infection resulting from esophageal perforation. Retrospective (2008-2012) processing of a group of surgically treated patients. The aspects assessed were aetiology, the surgical methods applied and the length of therapy. The total number of patients treated was 16. In 8 cases, the aetiology was iatrogenic (3 cases of leaking esophageal anastomosis in consequence of resection of the esophagus, 2 cases of perforation after fundoplication, 1 case of esophageal cardiomyotomy, and 2 cases of perforation during endoscopy). In 4 patients, the aetiology was spontaneous perforation, impacted foreign bodies caused difficulties to 3 patients, and the last cause was acid corrosive esophagitis. A stent was applied in all the patients at the site of the defect. The mediastinitis was drained through the access from thoracotomy or left thoracolaparotomy, respectively (8 cases), or by combination of laparotomy/laparostomy and pleural drainage (5 cases). Pleural (in 3 cases) and neck (1 case) drainage meant minimum intervention. Esophagectomy was not carried out in any of the patients. 4 patients died. The average period of time for which the stent was left in situ was 53.7 days; the average time of hospitalization in surviving patients was 53.4 days. Stent application does not show any difference regarding patients' survival (25% mortality), but enables shortening the total therapy time and, predominantly, preserving the native esophagus.


    • 1 April 2013
      • Vol. 92  (4) , 209-11

    [Double gallbladder - a rare congenital variation].

    by J Fichtl, V Treska, J Vodicka, R Tupý

    Double gallbladder, a congenital anatomic variation, represents approximately 2% of all congenital anatomic variations of the gastrointestinal tract, its incidence amounting to about 25 in 100 000. It has several types classified according to Boyden's criteria. The diagnostic method of first choice is ultrasonography. When the patient has no health complaints and cholecystolithiasis is present, no special treatment measures are required. The treatment option in symptomatic cholecystolithiasis is laparoscopic cholecystectomy. Only a few cases of double or triple gallbladder, in contrast to the high number of cholecystectomies, have been published in literature. The authors present a case of double gallbladder where the diagnosis was established more than three years after laparoscopic cholecystectomy

    • 1 July 2012
      • Vol. 91  (7) , 362-7

    [Descending necrotising mediastinitis - surgical management].

    by J Safránek, V Spidlen, T Skalický, J Vodička, J Martínek, P Andrle

    Descending necrotising mediastinitis (DNM) is a less common form of infection in the mediastinum caused by downward spread from the cervical, oral and pharyngeal regions. We retrospectively evaluate a group of patients who underwent surgical management of DNM at our department between 2007 and 2011. We operated on 7 patients (1 female, 6 males) with the mean age of 56.3 years. In 3 cases the infection was of odontogenic origin and in 4 cases of tonsillar origin. Except for one patient with permanent immunosuppression, after kidney transplantation, swab culture showed the original, inciting pathogen to be Streptococcus in all cases; as for anaerobic organisms it was mostly Fusobacterium. In all cases we performed external cervical drainage and mediastinal drainage through a cervical approach. In 3 cases it was necessary to perform mediastinal drainage through thoracotomy. Mean hospital stay was 45.7 days, 30-day mortality was zero. The results confirm a better prognosis of DNM compared to mediastinitis caused by oesophageal perforation or oesophageal surgery complication.

    • 1 February 2012
      • Vol. 91  (2) , 81-6

    [Surgical therapy of pulmonary metastases of colorectal cancer--ten-year results].

    by J Vodicka, V Spidlen, V Simánek, J Safránek, V Treska, T Skalický, A Sutnar, J Fichtl, P Mukensnabl

    Nowadays, surgical therapy of pulmonary metastases of colorectal cancer is a generally accepted therapeutic approach that has been proven to extend long term patient survival with acceptable perioperative morbidity and mortality rates. The aim of the study is to retrospectively analyse a group of patients who underwent surgery for pulmonary metastases of colorectal cancer over a period of ten years. From 2000 to 2009, 39 patients with pulmonary metastases of colorectal cancer underwent surgical therapy at the site of the authors, out of whom 21 were males (53.8%), with a mean age of 60.4 years. Out of the total, 24 patients (61.5%) presented with solitary metastases, multiple metastases were found in the remaining patients. 8 patients (20.5%) bileral affection was detected. 34 patients (87.2%) underwent adjuvant oncological therapy of a radically surgically curable primary tumor before metastasectomy and 6 patients (15.4%) underwent surgery for liver metastases. Five patients in the group (12.8%) had both pulmonary and secondary liver affections at the same time. The median disease-free period after the primary tumor surgery was 27 months in the whole group. In total, we performed 31 unilateral (79.5%) and 8 bilateral (20.5%) one- or two- step surgeries. The most common type of surgery included anatomical pulmonary resections (18 procedures), laser excisions (13 procedures) and wedge resections (9 procedures). In total, we performed 73 radical resections of metastases and 5 metastases were treated by radiofrequency ablation (RFA). Metastatic affection of hilar lymph nodes was found in three patients (7.7%). Perioperative morbidity reached 12.8%, mortality was zero, and two re-operations were required because of complications (5.1%). 53.8% of patients with metastasectomy are still alive, the median survival time is 38 months. The three-year survival rate is 52% and the five-year survival rate is 41% five years. Pre-operatively increased value of tissue polypeptid specific antigen (TPS) was the only statistically significant factor that had a negative impact on the overall survival. 30.7% of patients with metastasectomy show no disease progression, the median disease- free interval is 14 months. There is a statistically significant correlation between DFI (Disease Free Interval) following metastasectomy and the type of surgery and the lowest value of DFI was achieved with radiofrequency ablation. The risk of disease progression is 3.4-times higher in patients with two and more metastases of colorectal cancer up to 3.9-times higher in subjects with three and more metastases. The positive effect of pulmonary metastasectomy on the long-term survival is evident. However, careful selection of patients with individual evaluation of each single case is required. In particular, indication for metastasectomy should be carefuly considered in cases of multiple affection, which are associated with higher risk of disease progression. The essential requirement is to achieve complete resection of the pathological focus, with a maximum effort aimed at sparing healthy pulmonary tissue, which allows for potential necessary reoperations in case of the disease recurrence. Systematic mediastinal lymphadenectomy (SMLA) should be an integral part of any pulmonary metastasectomy.

    • 1 May 2011
      • Vol. 90  (5) , 277-80

    [Mediastinal cysts, surgical management].

    by J Safránek, V Spidlen, J Vodicka

    Mediastinal cysts are common lesions, affecting children, as well as adults. They account for 20-30 % pathological mediastinal masses. The treatment is surgical, including extirpation, respectively enucleation of the cyst. Assessment of the author's patient group and overview of current literature data. Retrospective analysis of a group of 11 patients (9 female and2 male subjects, the mean age was 47.6 years) indicated for scheduled procedures for mediastinal cysts from 2006 to 2010. Histological examination confirmed pericardial cysts in 7 subjects (63.6%), brochogenic cysts in 3 (27.3%) subjects and a thymic cyst in one subject (9.1%). The commonest location was anterior mediastinum - 7 subjects (63.6%), whereas upper mediastinum was the cyst site in 3 (27.3%) subjects and posterior mediastinum in 1 (9.1%) subject. Thoracotomy was indicated in 3 subjects, one subject was indicated for lung resection for carcinoma using thoracotomy and the pericardial cyst was a secondary known diagnosis, one patient was operated using sternotomy. 6 patients were indicated for videothoracoscopic (VTS) procedures and a decision to convert to thoracotomy was taken in 2 of these subjects. The patients were discharged from hospital 4-12 days after thoracotomy (the mean of 6.67 days), 3-4 days after VTS (the mean of 3.25 days), while the patient undergoing sternotomy was discharged on the postoperative Day 8. The mean size of the cysts removed using thoracotomy was 78 x 55 mm and the mean size of the cysts removed using VTS was 50 x 29 mm. The surgical technique for expected mediastinal cysts should be selected based on the cysts location, rather than on their size. The main objective is to indicate each mediastinal cyst for VTS (shorter duration of hospitalization) and eventual conversion to thoracotomy does not cause any delays or complications. Also asymptomatic cysts should be indicated for surgery.

    • 1 May 2009
      • Vol. 88  (5) , 253-8

    [Acute mediastinitis--optimum diagnostic and therapeutic measures].

    by J Klecka, V Simánek, J Vodicka, V Spidlen, R Pradl, J P Ferda

    The term of acute purulent mediastinitis (APM) is understood as a bacterial inflammatory process involving mediastinal tissue and organs. It is a group of clinical disorders originated primary or secondary as a complications another disease of different etiology. The definitive clinical picture is a combination of both pathologies. APM having obviously purulent character develops usually extremly fast and is objectively harming patient's life. In case of Descending Necrotizing Mediastinitis (DNM) the mortality is up to 25-40%. The only perfect and early stated diagnosis and choosen effective therapy mode can lead to patient life salvage and survival. The surgery share on therapy is substantional. During years 2004-2008 we have taken experience in this field by treatment of 18 patients with APM. Our conclusions after that most important condition for effective therapy is early and enough wide dissection of the involved area, mainly thoracocervical and mediastinal, their drainage and installation of the continual rinsing, eventually. There is no exception we indicate an operative repeated revision including rethoracotomy, if necessary.

    • 1 May 2009
      • Vol. 88  (5) , 262-3

    [Late diagnosed rupture of the diaphragm --a case review].

    by V Simánek, V Treska, J Klecka, V Spidlen, J Vodicka

    The authors describe a case of the patient with late diagnosis of the diaphragmatic rupture. There was a bowel obstruction found in X-ray scan. After endotracheal intubation was complicated of tension pneumotorax. Laparotomy was found rupture of the diaphragm.